Michael Donohue, Ph.D.
Affiliations: | 2005 | University of California, San Diego, La Jolla, CA |
Area:
MathematicsGoogle:
"Michael Donohue"Parents
Sign in to add mentor| Ian Abramson | grad student | 2005 | UCSD | |
| (Rank regression and synergy assessment.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Suzuki K, Hirakawa A, Ihara R, et al. (2020) Effect of apolipoprotein E ε4 allele on the progression of cognitive decline in the early stage of Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 6: e12007 |
| Mattsson N, Insel PS, Donohue M, et al. (2019) Predicting diagnosis and cognition with F-AV-1451 tau PET and structural MRI in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
| Aisen PS, Petersen RC, Donohue M, et al. (2015) Alzheimer's Disease Neuroimaging Initiative 2 Clinical Core: Progress and plans. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 734-9 |
| Mattsson N, Insel PS, Donohue M, et al. (2015) Predicting Reduction of Cerebrospinal Fluid β-Amyloid 42 in Cognitively Healthy Controls. Jama Neurology. 72: 554-60 |
| Mattsson N, Insel PS, Donohue M, et al. (2015) Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease. Brain : a Journal of Neurology. 138: 772-83 |
| Mattsson N, Insel PS, Landau S, et al. (2014) Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease. Annals of Clinical and Translational Neurology. 1: 534-43 |
| Sperling RA, Rentz DM, Johnson KA, et al. (2014) The A4 study: stopping AD before symptoms begin? Science Translational Medicine. 6: 228fs13 |
| Mattsson N, Tosun D, Insel PS, et al. (2014) Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment. Brain : a Journal of Neurology. 137: 1550-61 |
| Jack C, Knopman D, Jagust W, et al. (2013) O3-03-01: Update on hypothetical model of Alzheimer's disease biomarkers Alzheimer's & Dementia. 9: P521-P522 |
| Vellas B, Hampel H, Rougé-Bugat ME, et al. (2012) Alzheimer's disease therapeutic trials: EU/US Task Force report on recruitment, retention, and methodology. The Journal of Nutrition, Health & Aging. 16: 339-45 |